Compare PLAG & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAG | CCM |
|---|---|---|
| Founded | 1986 | 1997 |
| Country | United States | China |
| Employees | 6 | N/A |
| Industry | Packaged Foods | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6M | 19.0M |
| IPO Year | 2007 | 2009 |
| Metric | PLAG | CCM |
|---|---|---|
| Price | $1.69 | $5.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 40.6K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,040,616.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $3.18 |
| 52 Week High | $4.49 | $10.77 |
| Indicator | PLAG | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 61.99 |
| Support Level | $1.69 | $5.03 |
| Resistance Level | $1.78 | $5.41 |
| Average True Range (ATR) | 0.08 | 0.45 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 70.37 | 64.71 |
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.